Company: BIAF
Filing Date: 2025-05-07
Form Type: 424B4
Source: 0001641172-25-008977
Chunk: 134

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-05-07
Form: 424B4
Chunk 134
---
 meet our current needs and expected level of operations. We do not own any real property.

Legal Proceedings

We are not currently a party to any current or pending material legal proceedings. From time to time, however, the Company may be involved in various disputes and litigation matters that arise in the ordinary course of business. The Company may face claims brought by third parties, or, from time to time, the Company may make claims or take legal actions to assert our rights. Regardless of the outcome, any such claims or legal proceedings could adversely impact our business, reputation, operating results, and financial condition because of defense and settlement costs, diversion of resources, and other factors. Results of actual and potential litigation are inherently uncertain, and there can be no assurances that favorable outcomes will be obtained.

Implications of Being an Emerging Growth Company and a Smaller Reporting Company

We qualify as an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. For as long as we remain an emerging growth company, we may take advantage of specified reduced reporting requirements and other burdens that are otherwise applicable generally to other public companies. These provisions include, but are not limited to:

| ● | reduced                                                                                                                                
 obligations with respect to financial data, including presenting only two years of audited financial statements and selected financial 
 data, and only two years of related Management’s Discussion and Analysis of Financial Condition and Results of Operations disclosure   
 in our initial registration statement;                                                                                                 |
| ● | an                                                                                                                                     
 exemption from the auditor attestation requirement in the assessment of our internal control over financial reporting pursuant to      
 the Sarbanes-Oxley Act of 2002, as amended (“SOX”);                                                                                    |
| ● | reduced                                                                                                                                
 disclosure about executive compensation arrangements in our periodic reports, registration statements, and proxy statements; and       |
| ● | exemptions                                                                                                                             
 from the requirements to seek non-binding advisory votes on executive compensation or stockholder approval of any golden parachute     
 arrangements.                                                                                                                          |

| 63 |

We may take advantage of some or all of these provisions until we are no longer an emerging growth company. We will remain an emerging growth company until the earliest of (1) the last day of the fiscal year following the fifth anniversary of the completion of our initial public offering, (2) the last day of the first fiscal year in which our annual gross revenues exceed $1.235 billion, (3) the date on which we have, during the immediately preceding three-year period